Impel NeuroPharma initiates phase IIa trial of INP-103 in Parkinson's disease OFF episodes June 1, 2018
Researchers describe potent antitumoral activity of KY-1055, a dual anti-ICOS/PD-L1 antibody May 31, 2018
Syndax and Nektar collaborate to study combination of NKTR-214 with entinostat in melanoma May 31, 2018
Encouraging results seen with pegilodecakin plus pembrolizumab or nivolumab in NSCLC, RCC patients May 31, 2018
RSS